ArticleJournal of neuroinflammation2016

Circulating microRNAs as biomarkers for rituximab therapy, in neuromyelitis optica (NMO).

Adi Vaknin-Dembinsky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.